3,469
Views
30
CrossRef citations to date
0
Altmetric
Original Articles

Genetic and biochemical characterizations of Zika virus NS2A protein

, , , , , & show all
Pages 585-602 | Received 31 Dec 2018, Accepted 18 Mar 2019, Published online: 08 Apr 2019

References

  • Hamel R, Liegeois F, Wichit S, et al. Zika virus: epidemiology, clinical features and host-virus interactions. Microbes Infect. 2016;18(7–8):441–449. doi:10.1016/j.micinf.2016.03.009. PubMed PMID: WOS:000378848400001; English.
  • Chouin-Carneiro T, Vega-Rua A, Vazeille M, et al. Differential susceptibilities of Aedes aegypti and Aedes albopictus from the Americas to Zika virus. Plos Neglect Trop D. 2016;10(3):e0004543. doi:10.1371/journal.pntd.0004543. PubMed PMID: WOS:000373272500062; English.
  • Musso D, Roche C, Robin E, et al. Potential sexual transmission of Zika virus. Emerging Infect Dis. 2015;21(2):359–361. doi:10.3201/eid2102.141363. PubMed PMID: WOS:000348491400030; English.
  • Besnard M, Lastere S, Teissier A, et al. Evidence of perinatal transmission of Zika virus, French Polynesia, December 2013 and February 2014. Eurosurveillance. 2014;19(13):13–16. doi:10.2807/1560-7917.Es2014.19.13.20751. PubMed PMID:WOS:000334029600004; English.
  • Musso D, Nhan T, Robin E, et al. Potential for Zika virus transmission through blood transfusion demonstrated during an outbreak in French Polynesia, November 2013 to February 2014. Eurosurveillance. 2014;19(14):6–8. doi:10.2807/1560-7917.Es2014.19.14.20761. PubMed PMID: WOS:000334350200002; English.
  • Dick GWA, Kitchen SF, Haddow AJ. Zika virus (I). Isolations and serological specificity. T Roy Soc Trop Med H. 1952;46(5):509–520. doi:10.1016/0035-9203(52)90042-4. PubMed PMID: WOS:A1952XT98500007; English.
  • Duffy MR, Chen TH, Hancock WT, et al. Zika virus outbreak on yap Island, federated states of micronesia. New Engl J Med. 2009;360(24):2536–2543. doi:10.1056/Nejmoa0805715. PubMed PMID: WOS:000266813800008; English.
  • Musso D, Gubler DJ. Zika virus. Clin Microbiol Rev. 2016;29(3):487–524. doi:10.1128/Cmr.00072-15. PubMed PMID: WOS:000375057900003; English.
  • Musso D, Nilles EJ, Cao-Lormeau VM. Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infec. 2014;20(10):O595–O596. doi:10.1111/1469-0691.12707. PubMed PMID: WOS:000345825900002; English.
  • Campos GS, Bandeira AC, Sardi SI. Zika virus outbreak, Bahia, Brazil. Emerg Infect Dis. 2015;21(10):1885–1886. doi:10.3201/eid2110.150847. PubMed PMID: WOS:000362158000038; English.
  • Hennessey M, Fischer M, Staples JE. Zika virus spreads to new areas - region of the Americas, May 2015-January 2016. Am J Transplant. 2016;16(3):1031–1034. doi:10.1111/ajt.13743. PubMed PMID: WOS:000371240500036; English.
  • Xia HJ, Xie XP, Shan C, et al. Potential mechanisms for enhanced Zika epidemic and disease. Acs Infect Dis. 2018;4(5):656–659. doi:10.1021/acsinfecdis.8b00004. PubMed PMID: WOS:000432478400002; English.
  • Brasil P, Pereira JP, Moreira ME, et al. Zika virus infection in pregnant women in Rio de Janeiro. New Engl J Med. 2016;375(24):2321–2334. doi:10.1056/Nejmoa1602412. PubMed PMID: WOS:000390036500004; English.
  • Schuler-Faccini L, Ribeiro EM, Feitosa IML, et al. Possible association between Zika virus infection and microcephaly — Brazil, 2015. Mmwr-Morbid Mortal W. 2016;65(3):59–62. doi:10.15585/Mmwr.Mm6503e2. PubMed PMID: WOS:000369119300005; English.
  • Oehler E, Watrin L, Larre P, et al. Zika virus infection complicated by Guillain-Barre syndrome - case report, French Polynesia, December 2013. Eurosurveillance. 2014;19(9):4–6. PubMed PMID:WOS:000332933900002; English. doi: 10.2807/1560-7917.ES2014.19.9.20720
  • Dos Santos T, Rodriguez A, Almiron M, et al. Zika virus and the Guillain-Barre syndrome - case series from seven countries. New Engl J Med. 2016;375(16):1598–1601. doi:10.1056/Nejmc1609015. PubMed PMID: WOS:000393102500029; English.
  • Heymann DL, Hodgson A, Sall AA, et al. Zika virus and microcephaly: why is this situation a PHEIC? Lancet. 2016;387(10020):719–721. doi:10.1016/S0140-6736(16)00320-2. PubMed PMID: WOS:000370418000004; English.
  • Shan C, Xie X, Shi PY. Zika virus vaccine: progress and challenges. Cell Host Microbe. 2018;24(1):12–17. doi:10.1016/j.chom.2018.05.021. PubMed PMID: 30008291; PubMed Central PMCID: PMC6112613.
  • Xie X, Zou J, Shan C, et al. Small molecules and antibodies for Zika therapy. J Infect Dis. 2017;216(suppl_10):S945–S950. doi:10.1093/infdis/jix406. PubMed PMID: 29267911; PubMed Central PMCID: PMC5853826.
  • Barrows NJ, Campos RK, Powell ST, et al. A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe. 2016;20(2):259–70. doi:10.1016/j.chom.2016.07.004. PubMed PMID: 27476412; PubMed Central PMCID: PMC4993926.
  • Sapparapu G, Fernandez E, Kose N, et al. Neutralizing human antibodies prevent Zika virus replication and fetal disease in mice. Nature. 2016;540(7633):443–447. doi:10.1038/nature20564. PubMed PMID: 27819683; PubMed Central PMCID: PMC5583716.
  • Zou J, Shi PY. Strategies for Zika drug discovery. Curr Opin Virol. 2019;35:19–26. doi:10.1016/j.coviro.2019.01.005. PubMed PMID: 30852345.
  • Mlakar J, Korva M, Tul N, et al. Zika virus associated with microcephaly. New Engl J Med. 2016;374(10):951–958. doi:10.1056/Nejmoa1600651. PubMed PMID: WOS:000371660000008; English.
  • Lindenbach BD, Thiel H-J, Rice CM. Flaviviridae: the viruses and their replication. In: Knipe DM, Howley PM, Griffin DE, et al., editors. Fields virology. 5th ed. Vol. 1. Philadelphia, PA: Lippincott Williams & Wilkins; 2007. p. 1101–1152.
  • Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle M, et al. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci U S A. 2003;100(24):14333–14338. doi:10.1073/pnas.2335168100. PubMed PMID: WOS:000186803800104; English.
  • Xia HJ, Luo HL, Shan C, et al. An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction. Nat Commun. 2018;9. doi:10.1038/s41467-017-02816-2. PubMed PMID: WOS:000423431900001; English.
  • Falgout B, Markoff L. Evidence that flavivirus Ns1-Ns2a cleavage is mediated by a membrane-bound host protease in the endoplasmic-reticulum. J Virol. 1995;69(11):7232–7243. PubMed PMID: WOS:A1995RZ10000077; English.
  • Chambers TJ, Mccourt DW, Rice CM. Production of yellow-fever virus proteins in infected-cells - identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera. Virology. 1990;177(1):159–174. doi:10.1016/0042-6822(90)90470-C. PubMed PMID: WOS:A1990DK26100017; English.
  • Mackenzie JM, Khromykh AA, Jones MK, et al. Subcellular localization and some biochemical properties of the flavivirus Kunjin nonstructural proteins NS2A and NS4A. Virology. 1998;245(2):203–215. doi:10.1006/viro.1998.9156. PubMed PMID: WOS:000074186800004; English.
  • Xie XP, Zou J, Puttikhunt C, et al. Two distinct sets of NS2A molecules are responsible for dengue virus RNA synthesis and virion assembly. J Virol. 2015;89(2):1298–1313. doi:10.1128/Jvi.02882-14. PubMed PMID: WOS:000347178900035; English.
  • Wu RH, Tsai MH, Chao DY, et al. Scanning mutagenesis studies reveal a potential intramolecular interaction within the C-terminal half of dengue virus NS2A involved in viral RNA replication and virus assembly and secretion. J Virol. 2015;89(8):4281–4295. doi:10.1128/Jvi.03011-14. PubMed PMID: WOS:000352218400022; English.
  • Kummerer BM, Rice CM. Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles. J Virol. 2002;76(10):4773–84. PubMed PMID: 11967294; PubMed Central PMCID: PMC136122. doi: 10.1128/JVI.76.10.4773-4784.2002
  • Leung JY, Pijlman GP, Kondratieva N, et al. Role of nonstructural protein NS2A in flavivirus assembly. J Virol. 2008;82(10):4731–4741. doi:10.1128/Jvi.00002-08. PubMed PMID: WOS:000255619600005; English.
  • Liu WJ, Chen HB, Khromykh AA. Molecular and functional analyses of Kunjin virus infectious cDNA clones demonstrate the essential roles for NS2A in virus assembly and for a nonconservative residue in NS3 in RNA replication. J Virol. 2003;77(14):7804–7813. doi:10.1128/Jvi.77.14.7804-7813.2003. PubMed PMID: WOS:000183899200012; English.
  • Vossmann S, Wieseler J, Kerber R, et al. A basic cluster in the N terminus of yellow fever virus NS2A contributes to infectious particle production. J Virol. 2015;89(9):4951–4965. doi:10.1128/Jvi.03351-14. PubMed PMID: WOS:000352219600023; English.
  • Shan C, Xie XP, Zou J, et al. Using a virion assembly-defective dengue virus as a vaccine approach. J Virol. 2018;92(21). doi:10.1128/JVI.01002-18. PubMed PMID: WOS:000447139100013; English.
  • Tu YC, Yu CY, Liang JJ, et al. Blocking double-stranded RNA-activated protein kinase PKR by Japanese encephalitis virus nonstructural protein 2A. J Virol. 2012 Oct;86(19):10347–10358. doi:10.1128/Jvi.00525-12. PubMed PMID: WOS:000308740700010; English.
  • Liu WJ, Wang XJ, Clark DC, et al. A single amino acid substitution in the west Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J Virol. 2006;80(5):2396–2404. doi:10.1128/Jvi.80.5.2396-2404.2006. PubMed PMID: WOS:000235388400032; English.
  • Wen JL, Hua BC, Xiang JW, et al. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol. 2004;78(22):12225–12235. doi:10.1128/Jvi.78.22.12225-12235.2004. PubMed PMID: WOS:000224781400014; English.
  • Wu RH, Tsai MH, Tsai KN, et al. Mutagenesis of dengue virus protein NS2A revealed a novel domain responsible for virus-induced cytopathic effect and interactions between NS2A and NS2B transmembrane segments. J Virol. 2017;91(12). doi:10.1128/JVI.01836-16. PubMed PMID: WOS:000402169500027; English.
  • Melian EB, Edmonds JH, Nagasaki TK, et al. West Nile virus NS2A protein facilitates virus-induced apoptosis independently of interferon response. J Gen Virol. 2013;94:308–313. doi:10.1099/vir.0.047076-0. PubMed PMID: WOS:000315546100008; English.
  • Yoon KJ, Song G, Qian XY, et al. Zika-virus-encoded NS2A disrupts mammalian cortical neurogenesis by degrading adherens junction proteins. Cell Stem Cell. 2017;21(3):349–358.e6. doi:10.1016/j.stem.2017.07.014. PubMed PMID: WOS:000409527700012; English.
  • Shan C, Xie XP, Muruato AE, et al. An infectious cDNA clone of Zika virus to study viral virulence, mosquito transmission, and antiviral inhibitors. Cell Host Microbe. 2016;19(6):891–900. doi:10.1016/j.chom.2016.05.004. PubMed PMID: WOS:000377447000019; English.
  • Xie XP, Zou J, Shan C, et al. Zika virus replicons for drug discovery. Ebiomedicine. 2016;12:156–160. doi:10.1016/j.ebiom.2016.09.013. PubMed PMID: WOS:000386878500031; English.
  • Miller S, Sparacio S, Bartenschlager R. Subcellular localization and membrane topology of the dengue virus type 2 non-structural protein 4B. J Biol Chem. 2006;281(13):8854–8863. doi:10.1074/jbc.M512697200. PubMed PMID: WOS:000236247100065; English.
  • Xie XP, Gayen S, Kang CB, et al. Membrane topology and function of dengue virus NS2A protein. J Virol. 2013;87(8):4609–4622. doi:10.1128/Jvi.02424-12. PubMed PMID: WOS:000316671000043; English.
  • Hooper R, Churamani D, Brailoiu E, et al. Membrane topology of NAADP-sensitive two-pore channels and their regulation by N-linked glycosylation. J Biol Chem. 2011;286(11):9141–9149. doi:10.1074/jbc.M110.189985. PubMed PMID: WOS:000288247700045; English.
  • Rossi SL, Fayzulin R, Dewsbury N, et al. Mutations in West Nile virus nonstructural proteins that facilitate replicon persistence in vitro attenuate virus replication in vitro and in vivo. Virology. 2007;364(1):184–195. doi:10.1016/j.virol.2007.02.009. PubMed PMID: WOS:000247198200021; English.
  • Patkar CG, Kuhn RJ. Yellow fever virus NS3 plays an essential role in virus assembly independent of its known enzymatic functions. J Virol. 2008;82(7):3342–3352. doi:10.1128/Jvi.02447-07. PubMed PMID: WOS:000254139800015; English.
  • Lobigs M, Lee E. Inefficient signalase cleavage promotes efficient nucleocapsid incorporation into budding flavivirus membranes. J Virol. 2004;78(1):178–186. doi:10.1128/Jvi.78.1.178-186.2004. PubMed PMID: WOS:000187451700018; English.
  • Stocks CE, Lobigs M. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. J Virol. 1998;72(3):2141–2149. PubMed PMID: WOS:000071997600052; English.
  • Amberg SM, Rice CM. Mutagenesis of the NS2B-NS3-mediated cleavage site in the flavivirus capsid protein demonstrates a requirement for coordinated processing. J Virol. 1999;73(10):8083–8094. PubMed PMID: WOS:000082554300019; English.
  • Khromykh AA, Varnavski AN, Sedlak PL, et al. Coupling between replication and packaging of flavivirus RNA: evidence derived from the use of DNA-based full-length cDNA clones of Kunjin virus. J Virol. 2001;75(10):4633–4640. doi:10.1128/Jvi.75.10.4633-4640.2001. PubMed PMID: WOS:000168309300017; English.
  • Welsch S, Miller S, Romero-Brey I, et al. Composition and three-dimensional architecture of the dengue virus replication and assembly sites. Cell Host Microbe. 2009;5(4):365–375. doi:10.1016/j.chom.2009.03.007. PubMed PMID: WOS:000265571600009; English.
  • Xie XP, Yang YJ, Muruato AE, et al. Understanding Zika virus stability and developing a chimeric vaccine through functional analysis. Mbio. 2017;8(1). doi:10.1128/mBio.02134-16. PubMed PMID: WOS:000395835000086; English.
  • Shan C, Muruato AE, Nunes BTD, et al. A live-attenuated Zika virus vaccine candidate induces sterilizing immunity in mouse models. Nat Med. 2017;23(6):763–767. doi:10.1038/nm.4322. PubMed PMID: WOS:000402768000019; English.
  • Xie XP, Kum DPB, Xia HJ, et al. A single-dose live-attenuated Zika virus vaccine with controlled infection rounds that protects against vertical transmission. Cell Host Microbe. 2018;24(4):487–499.e5. doi:10.1016/j.chom.2018.09.008. PubMed PMID: WOS:000446888300008; English.